Comparison of breast and gastric HER2 immunohistochemistry (IHC) scoring criteria in the assessment of endometrial carcinoma

Authors

Rachel L Furuya, Washington University School of Medicine in St. Louis
Whitney Grither, Washington University School of Medicine in St. Louis
Matthew A Powell, Washington University School of Medicine in St. Louis
Premal H Thaker, Washington University School of Medicine in St. Louis
et al.

Journal

Gynecologic Oncology

Publication Date

1-1-2026

Volume

204

First Page

17

Last Page

22

Document Type

Open Access Publication

DOI

10.1016/j.ygyno.2025.10.034

Rights and Permissions

Furuya RL, Grither W, Evans MG, Wu S, Hechtman JF, Krause HB, Elliott A, Mathews C, Oliver MT, Miller K, Wei S, Ali-Fehmi R, Bryant DA, Oberley MJ, Powell MA, Thaker PH. Comparison of breast and gastric HER2 immunohistochemistry (IHC) scoring criteria in the assessment of endometrial carcinoma. Gynecol Oncol. 2026 Jan;204:17-22. doi: 10.1016/j.ygyno.2025.10.034. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/ licenses/by/4.0/).

Recommended Citation

Furuya, Rachel L; Grither, Whitney; Powell, Matthew A; Thaker, Premal H; and et al., "Comparison of breast and gastric HER2 immunohistochemistry (IHC) scoring criteria in the assessment of endometrial carcinoma." Gynecologic Oncology. 204, 17 - 22. (2026).
https://digitalcommons.wustl.edu/oa_4/6355

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.